Cite

HARVARD Citation

    Leboulleux, S. et al. (n.d.). 1819OTumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer. Annals of oncology. p. . [Online]. 
  
Back to record